Epithelioid hemangioendothelioma
MONDO:0015523A low-grade malignant blood vessel neoplasm. It is characterized by the presence of epithelioid endothelial cells. The neoplastic cells are arranged in cords and nests, which are embedded in a myxoid to hyalinized stroma.
Also known as: epithelioid angioendothelioma, epithelioid angiosarcoma, epithelioid hemangioendothelioma, malignant epithelioid hemangioendothelioma
2751 clinical trials for this condition and its sub-types, 13 tagged with Epithelioid hemangioendothelioma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →-
Experimental drug targets rare cancer that often defies treatment
Disease control Not yet recruitingThis phase 2 trial tests a drug called nab-sirolimus in people with a rare cancer called epithelioid hemangioendothelioma (EHE) that is getting worse or causing symptoms. The drug is given through a vein and aims to shrink or control the tumors. The study will measure how many pa…
Phase 2 • Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New pill targets cancer growth pathway in advanced tumors
Disease control Not yet recruitingThis study tests a new drug called TYK-01054 for people with advanced solid tumors that have not responded to standard treatments. The drug is taken as a capsule and works by blocking a protein (TEAD) involved in cancer growth. The trial will check safety, find the best dose, and…
Phase 1/2 • Sponsor: TYK Medicines, Inc • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC